Olesen Value Fund sells 1,488 Solitron shares
Olesen Value Fund L.P., a more-than-10% owner of Solitron Devices, reported selling 1,488 shares of common stock on July 22, 2026 at $29.84 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Olesen Value Fund L.P., a more-than-10% owner of Solitron Devices, reported selling 1,488 shares of common stock on July 22, 2026 at $29.84 per share. After these sales, the filing reports 216,508 shares of common stock beneficially owned. Related entities Olesen Value Fund GP LLC, Olesen Capital Management LLC and Christian Olesen may be deemed beneficial owners of the fund’s shares, and each disclaims beneficial ownership beyond its or his pecuniary interest.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, $0.01 par value F1 | 372 | $29.84 | $11K |
| Sale | Common Stock, $0.01 par value F1, F2 | 372 | $29.84 | $11K |
| Sale | Common Stock, $0.01 par value F1, F3 | 372 | $29.84 | $11K |
| Sale | Common Stock, $0.01 par value F1, F4 | 372 | $29.84 | $11K |
Footnotes (4)
- F1. This Form 4 is filed jointly by Olesen Value Fund L.P., Olesen Value Fund GP LLC, Olesen Capital Management LLC and Christian Olesen, the address of each of which is c/o Olesen Capital Management LLC, 185 Hudson Street, Suite 2539, Jersey City, NJ 07311 (collectively, the "Reporting Persons"). Each Reporting Person disclaims beneficial ownership of the shares of common Stock reported herein except to the extent of its or his pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such shares of Common Stock for purposes of Section 16 or for any other purpose.
- F2. Shares of Common Stock beneficially owned directly by Olesen Value Fund L.P. Olesen Value Fund GP LLC, as the general partner of Olesen Value Fund L.P., may be deemed the beneficial owner of the shares of Common Stock beneficially owned by Olesen Value Fund L.P.
- F3. Shares of Common Stock beneficially owned directly by Olesen Value Fund L.P. Olesen Capital Management LLC, as the investment manager of Olesen Value Fund L.P., may be deemed the beneficial owner of the shares of Common Stock beneficially owned by Olesen Value Fund L.P.
- F4. Shares of Common Stock beneficially owned directly by Olesen Value Fund L.P. Christian Olesen, as the managing member of Olesen Value Fund GP LLC and Olesen Capital Management LLC, may be deemed the beneficial owner of the shares of Common Stock beneficially owned by Olesen Value Fund L.P.
Key Figures
Key Terms
beneficial ownership regulatory
pecuniary interest regulatory
Section 16 regulatory
general partner financial
investment manager financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Olesen Value Fund L.P. report for Solitron Devices (SODI)?
Were the recent Solitron Devices (SODI) insider sales under a Rule 10b5-1 trading plan?
Who are the reporting persons associated with this Solitron Devices (SODI) Form 4?
What kind of security was traded in the Solitron Devices (SODI) Form 4?
How many individual sale transactions did Olesen Value Fund L.P. report for Solitron Devices (SODI)?
AI-generated analysis. How Rhea-AI works. Not financial advice.